<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01383226</url>
  </required_header>
  <id_info>
    <org_study_id>S53313</org_study_id>
    <nct_id>NCT01383226</nct_id>
  </id_info>
  <brief_title>Linear Endosonography for the Assessment of Sarcoidosis Stage O</brief_title>
  <acronym>LASSO</acronym>
  <official_title>CT Enlarged Mediastinal/Hilar Lymph Nodes Not Visible on Chest X-ray in the Non Cancer Patient : Diagnosis and Clinical Implications Using Endobronchial or Esophageal Ultrasound Controlled Needle Aspiration E(B)US-NA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients are often referred for E(B)US examination and sampling of enlarged mediastinal
      and/or hilar lymph nodes that are not visible on a standard chest X-ray but are discovered by
      accident on CT scan performed outside the context of lung cancer or extrathoracic
      malignancies. Since CT scan is largely used and E(B)US is a minimally invasive technique,
      these cases are explored more frequently but so far nothing is known, however, on the
      prevalence of abnormal findings in EBUS sampling in this particular population and on the
      clinical implications (mainly therapeutical implications) of E(B)US findings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim is to assess the nature and prevalence of abnormal findings in samplings
      obtained during E(B)US-NA in the non-cancer patient with CT enlarged mediastinal/hilar lymph
      nodes that are not visible on chest X-ray. As secondary aims, the clinical implications of
      E(B)US-NA findings will be assessed, in particular the number of cases where a specific
      treatment is initiated.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic sensitivity</measure>
    <time_frame>One year</time_frame>
    <description>The primary aim is to assess the nature and prevalence of abnormal findings in samplings obtained during E(B)US-NA in the non-cancer patient with CT enlarged mediastinal/hilar lymph nodes that are not visible on chest X-ray.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical impact.</measure>
    <time_frame>One year</time_frame>
    <description>As secondary aims, the clinical implications of E(B)US-NA findings will be assessed, in particular the number of cases where a specific treatment is initiated.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lymphadenitis</condition>
  <arm_group>
    <arm_group_label>Thoracic endosonography</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Thoracic endosonography, either endobronchial or esophageal ultrasound controlled needle aspiration, is a minimally invasive diagnostic technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic endosonography</intervention_name>
    <description>Thoracic endosonography is a minimal invasive diagnostic intervention</description>
    <arm_group_label>Thoracic endosonography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient referred to bronchoscopy for tissue diagnosis of discrete enlarged (≥10mm
             short axis diameter) mediastinal/hilar lymph nodes on CT scan that can be sampled by
             E(B)US-NA.

        Exclusion Criteria:

          -  Abnormal chest X-ray showing hilar/mediastinal lymph nodes

          -  Patients with suspected lung cancer

          -  Patients with previous malignancy diagnosed and definitely treated less than 5 years
             previously or, if treated more than five years before but with subsequent evidence of
             recurrence less than 5 years previously.

          -  Patient with concomitant (suspected or confirmed) bronchopulmonary infection or
             treated with antibiotics within the 4 previous weeks

          -  Patients with a contraindication for bronchoscopy and tissue sampling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe A Dooms, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent Ninane, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Saint-Pierre Brussels</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Middelheim Ziekenhuis</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Pierre Bruxelles</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Charleroi</name>
      <address>
        <city>Charleroi</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heilig Hart Ziekenhuis Roeselare</name>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint-Elisabeth Ziekenhuis</name>
      <address>
        <city>Turnhout</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Université Catholic Louvain</name>
      <address>
        <city>Woluwe</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2011</study_first_posted>
  <last_update_submitted>October 8, 2013</last_update_submitted>
  <last_update_submitted_qc>October 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endosonography</keyword>
  <keyword>enlarged thoracic lymph adenopathies</keyword>
  <keyword>non-cancer patient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphadenitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

